Reply to the letter to the editor concerning the review Immunotherapy for pet allergies.
作者信息
Virtanen Tuomas
机构信息
a Clinical Microbiology, University of Eastern Finland , Kuopio , Finland.
出版信息
Hum Vaccin Immunother. 2018 Jun 3;14(6):1442-1443. doi: 10.1080/21645515.2018.1449554. Epub 2018 Apr 11.
Abstract
摘要
相似文献
1
Reply to the letter to the editor concerning the review Immunotherapy for pet allergies.
Hum Vaccin Immunother. 2018 Jun 3;14(6):1442-1443. doi: 10.1080/21645515.2018.1449554. Epub 2018 Apr 11.
2
Reply to the Letter to the Editor: Reduced neuropsychiatric events as "beneficial reactions" to drugs: Seek associations with caution.
Brain Behav Immun. 2020 Feb;84:277. doi: 10.1016/j.bbi.2019.11.012. Epub 2019 Nov 18.
3
[Allergies as a target of interest in the era of immunotherapy].
Rev Med Inst Mex Seguro Soc. 2019 Dec 30;57(6):379-386.
4
Allergen Immunotherapy.
Prim Care. 2016 Sep;43(3):487-94. doi: 10.1016/j.pop.2016.04.004.
5
Reply.
J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):2099-2101. doi: 10.1016/j.jaip.2019.04.008.
6
To mix or not to mix in allergy immunotherapy vaccines.
Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):583-589. doi: 10.1097/ACI.0000000000000784.
7
[Specific immunotherapy in allergies--evaluation of current status].
Wien Med Wochenschr. 1996;146(15):422-5.
8
One Child's Food Fight: A Case Study of Oral Immunotherapy Treatment for Food Allergies.
J Pediatr Health Care. 2018 Jul-Aug;32(4):416-421. doi: 10.1016/j.pedhc.2018.01.004. Epub 2018 Mar 12.
9
Oral immunotherapy for the treatment of food allergy.
Hum Vaccin Immunother. 2014;10(8):2295-302. doi: 10.4161/hv.29233.
10
Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy').
Allergy. 2008 Jul;63(7):939-40. doi: 10.1111/j.1398-9995.2008.01648.x.
本文引用的文献
1
Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy?
Hum Vaccin Immunother. 2018 Jun 3;14(6):1438-1441. doi: 10.1080/21645515.2018.1434383. Epub 2018 Feb 23.
2
Immunotherapy for pet allergies.
Hum Vaccin Immunother. 2018 Apr 3;14(4):807-814. doi: 10.1080/21645515.2017.1409315. Epub 2017 Dec 21.
3
Human memory CD4+ T cell response to the major dog allergen Can f 5, prostatic kallikrein.
Clin Exp Allergy. 2016 May;46(5):720-9. doi: 10.1111/cea.12694.
4
Characterization of human memory CD4(+) T-cell responses to the dog allergen Can f 4.
J Allergy Clin Immunol. 2015 Oct;136(4):1047-54.e10. doi: 10.1016/j.jaci.2015.02.025. Epub 2015 Apr 3.
5
Human CD4+ T cell responses to the dog major allergen Can f 1 and its human homologue tear lipocalin resemble each other.
PLoS One. 2014 May 29;9(5):e98461. doi: 10.1371/journal.pone.0098461. eCollection 2014.
6
Differential CD4+ T-cell responses of allergic and non-allergic subjects to the immunodominant epitope region of the horse major allergen Equ c 1.
Immunology. 2014 Jan;141(1):52-60. doi: 10.1111/imm.12166.
7
Mammal-derived respiratory lipocalin allergens do not exhibit dendritic cell-activating capacity.
Scand J Immunol. 2013 Mar;77(3):171-6. doi: 10.1111/sji.12023.
8
Mammalian lipocalin allergens--insights into their enigmatic allergenicity.
Clin Exp Allergy. 2012 Apr;42(4):494-504. doi: 10.1111/j.1365-2222.2011.03903.x. Epub 2011 Nov 9.
9
Allergen-specific naïve and memory CD4+ T cells exhibit functional and phenotypic differences between individuals with or without allergy.
Eur J Immunol. 2010 Sep;40(9):2460-9. doi: 10.1002/eji.201040328.
10
Comparison of the allergic and nonallergic CD4+ T-cell responses to the major dog allergen Can f 1.
J Allergy Clin Immunol. 2010 Aug;126(2):406-8, 408.e1-4. doi: 10.1016/j.jaci.2010.06.005. Epub 2010 Jul 10.
Zotero 插件